Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Plos One|January 6, 2012
Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysisAmita Gupta, Girish Nadkarni, Wei-Teng Yang, et al.
Ebiomedicine|March 26, 2016
Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral TherapyShruthi Ravimohan, Neo Tamuhla, Shiang-Ju Kung, et al.
Tuberculosis (Edinburgh, Scotland)|November 14, 2022
Pharmacogenetic variability and the probability of site of action target attainment during tuberculosis meningitis treatment: A physiologically based pharmacokinetic modeling and simulations studyKrina Mehta, Navaneeth Narayanan, Scott K Heysell, et al.
The Journal of Infectious Diseases|January 21, 2014
Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility testsNicola M Zetola, Chawangwa Modongo, Patrick K Moonan, et al.
Plos Medicine|May 23, 2008
Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapyGregory P Bisson, Robert Gross, Scarlett Bellamy, et al.
Plos One|November 19, 2013
Tuberculin skin test result and risk of death among persons with active TBSara C Auld, Eleanor S Click, Charles M Heilig, et al.
BMC Infectious Diseases|October 8, 2013
Association between tuberculin skin test result and clinical presentation of tuberculosis diseaseSara C Auld, Eleanor S Click, Charles M Heilig, et al.
The Journal of Antimicrobial Chemotherapy|May 5, 2017
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TBChristopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, et al.
PLOS Global Public Health|July 23, 2025
Assessment of comorbidities, risk factors, and post tuberculosis lung disease in National Tuberculosis Guidelines: A scoping reviewMuhammed S Bah, Kyaw Ko Ko Htet, Gregory P Bisson, et al.
Plos One|November 3, 2017
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activationChristopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, et al.
Pageof 8